Investigating Failures in Purified Water Systems: Practical Insights

Purified water is essential in the pharmaceutical sector, serving various roles throughout production processes. However, failures in water systems can lead to significant quality issues, impacting product integrity and compliance. This article examines two notable case studies that illustrate common failures and approaches to troubleshooting purified water systems.

Overview: case Study 1: Addressing Microbial Contamination

Context

A pharmaceutical manufacturing facility located in Baddi Industrial Area, India, sought assistance in resolving persistent microbial contamination in their purified water system. These recurring issues prompted concerns over production delays and product quality.

Identifying the Problem

Despite routine disinfection protocols, both bacterial contamination and endotoxin levels consistently exceeded acceptable limits, indicating a fundamental issue within the system.

Methodical Troubleshooting

1. Root Cause Investigation: A detailed analysis revealed significant biofilm formation within the distribution pipeline, serving as a reservoir for microbial growth, ultimately undermining the effectiveness of standard disinfection practices.
2. System Evaluation: An assessment of the system’s design and operational procedures highlighted deficiencies that contributed to biofilm development, notably inadequate flushing protocols.
3. Real-time Monitoring: To facilitate immediate detection of microbial contamination, a laser-induced fluorescence (LIF) system was integrated into the water system. Additionally, regular microbial testing from various user points was established to maintain compliance with specifications.
4. Process Improvements: An enhanced disinfection strategy was introduced, incorporating periodic chemical cleanings and thermal sterilisation of the distribution lines at 80°C for four hours. Modifications were made to reduce dead legs within the system.
5. Personnel Training: Staff responsible for the purification system received training on effective disinfection procedures and strategies to prevent biofilm formation.

Results

Through implementing these corrective measures, the root cause of the microbial contamination was effectively addressed. The purification system achieved acceptable microbial counts, alleviating production delays and restoring product quality.

Overview: case Study 2: Managing Inadequate Water Quality

Context

A well-established pharmaceutical firm in Egypt reported issues with the quality of their purified water, as routine analyses indicated out-of-specification results.

Identifying the Problem

Increased levels of Total Organic Carbon (TOC) and conductivity posed risks to product quality, necessitating immediate action.

Methodical Troubleshooting

1. Root Cause Investigation: A comprehensive review of analytical data, system performance, and maintenance records revealed that a compromised reverse osmosis (RO) membrane allowed organic contaminants to pass through, contributing to elevated TOC and conductivity.
2. Equipment Assessment: The performance of the RO membrane was evaluated using integrity testing, which confirmed the need for intervention. Issues in the pretreatment process also contributed to elevated carbon levels.
3. Validation Review: The validation documentation for the purified water system was scrutinised and updated to comply with regulatory standards. A systematic validation of the water system confirmed adherence to necessary guidelines.
4. Process Improvements: Corrective actions were implemented to address the membrane and pretreatment concerns. The defective RO membrane was replaced, and a monitoring system was established to detect increases in TOC at an early stage.
5. Regulatory Compliance: The facility ensured compliance with regulatory expectations through the implementation of corrective actions, submitting validation and action reports to the relevant authorities.

Results

As a result of these corrective actions, the facility successfully restored the integrity and quality of their purified water system. The water now meets regulatory specifications, ensuring the preservation of product quality throughout manufacturing.

These two case studies underscore the significance of proactive oversight, thorough root cause investigations, and timely corrective actions in addressing common water system failures. By adopting these strategies, pharmaceutical companies can effectively enhance water quality and maintain compliance with regulatory standards.